InvestorsHub Logo
Followers 31
Posts 913
Boards Moderated 0
Alias Born 12/23/2009

Re: dia76ca post# 204678

Sunday, 02/01/2015 3:31:53 AM

Sunday, February 01, 2015 3:31:53 AM

Post# of 346390
By repeating again and again that the BOD is no good is not going to make the BOD no good. Lately this has become like the mantra here and for some an absolute truth, but I honestly do not know if the BOD is good or bad... Maybe in the past they made mistakes, I do not know. But now, I am not sure PPHM should be doing anything different.

The partner? Sure, it would be great to have one, but not at any cost.

This is what S. Worsley said last July:

We continue to have discussions with numerous potential partners and updating them with new data as it emerges from the program. If they’re in an immune-oncology space or have a drug candidate that can be leveraged by the immune-stimulatory mechanism of bavituximab, they’re certainly on our radar. This past quarter with data from keystone at AACR in hand, we were able to engage several prominent companies. This is a process that takes time and should not be rushed



So, yes it is taking time. It should not be rushed and I find VERY interesting that there was no comment about "partnership" in last CC.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News